Introduction: Pancreatic cancer is one of the most lethal gastrointestinal tumors, characterized by a low five-year survival rate and difficulty in early detection. Despite technological advances in medicine and improvements in outcomes for other types of cancer, the incidence and mortality of pancreatic cancer continue to grow progressively worldwide, representing an increasing challenge for public health. The anatomical location of the pancreas often delays diagnosis, resulting in advanced stages of the disease at the time of detection. In this context, the analysis of the epidemiological profile of patients hospitalized for pancreatic cancer becomes fundamental for understanding the disease dynamics and for developing prevention and early diagnosis strategies. Objectives: To characterize the epidemiological profile of hospitalizations for pancreatic cancer in Brazil in the period from 2019 to 2023, based on the analysis of sociodemographic variables and clinical outcomes. Methods: This is an observational, descriptive, ecological, and retrospective study with a quantitative approach, developed from the analysis of secondary data extracted from the Informatics Department of the Unified Health System (DATASUS), referring to hospitalizations for pancreatic cancer in Brazil, in the period from 2019 to 2023. The information was organized into spreadsheets using Microsoft Excel 365 software and analyzed through simple descriptive statistics. The variables considered for the analysis were: age group, sex, number of hospitalizations, and number of deaths. Results: In the analyzed period, a total of 75,201 cases of hospitalization were recorded. The geographical distribution of these hospitalizations was as follows: 46.34% occurred in the Southeast region, 26.64% in the South, 17.18% in the Northeast, 6.87% in the Midwest, and 2.97% in the North region. Regarding age group, it was observed that 78.5% of hospitalizations occurred in individuals aged between 50 and 79 years, with emphasis on the age group of 60 to 69 years, which accounted for 33% of the cases. The distribution by sex was balanced, with 50.2% of hospitalized patients being male and 49.8% female. In the same period, 61,829 deaths by residence were recorded in Brazil, with 49.46% of these deaths being men and 50.53% women. Conclusion: The analysis of hospitalizations for pancreatic cancer in Brazil between 2019 and 2023 shows a predominance of hospitalizations in the 50 to 79-year-old age group, with emphasis on individuals aged 60 to 69 years. The geographical and sex distribution, as well as the high number of deaths, points to the need for more effective strategies for early diagnosis and treatment of the disease.
It is with great enthusiasm that we present the Annals of the Oncology International Symposium 2025, an event that continues to solidify its significance in the oncology landscape of northern Brazil. Held in Belém, Pará, Oncology 2025 centered around the theme "The cancer control challenge: better knowing it to best facing it," dedicating itself to exploring the latest frontiers in cancer treatment and prevention.
This year, the symposium provided a deep dive into the essential role of knowledge in the fight against cancer, presenting new perspectives and scientific advancements across various areas of oncology. Renowned global experts gathered to share their most recent research and innovative approaches, offering participants a comprehensive view of the challenges faced by healthcare professionals and patients worldwide.
Presentations and discussions during the event focused on critical topics such as the use of new technologies, advancements in personalized therapies, and more effective prevention strategies. Additionally, particular attention was given to the unique challenges faced by the Amazon region, with efforts aimed at developing region-specific solutions to meet local needs.
Beyond being a high-caliber academic event, Oncology 2025 stood out as a moment for integration and professional networking, with the warm hospitality of the city of Belém offering participants a unique experience. This event became a platform for exchanging ideas, where science, culture, and humanity came together in pursuit of a common goal: to improve cancer control both in Brazil and globally.
This collection of abstracts and articles presented during the event reflects the ongoing dedication to research and the development of innovative solutions, highlighting the importance of collaboration and shared knowledge in the fight against cancer.
General Submission Guidelines:
The presenting author, who does not have to be the first author, must be registered for Oncology 2025.
Each abstract may have up to 10 authors, including the main author and co-authors.
Only original, unpublished work will be accepted.
Submissions must be related to oncology. However, project descriptions, work proposals, experience reports, and literature reviews will not be considered.
Clinical case reports are allowed, provided the abstract addresses scientific questions, details clinical observations, and includes primary scientific data.
The abstract must be written in English, but presentations may be given in Portuguese.
Abstracts must be between 300 and 500 words.
Comissão Organizadora
Comissão Científica
See Annals of Oncology 2023 at:
https://www.even3.com.br/anais/oncology-2023-international-symposium/
Complete tool for submission, evaluation and publication of proceedings for scientific events.
